Variables | 1 | 2 | 3 | 4 | 5 | 6 |
Ln (Private R&D investment) | Ln (New product sales) | Ln (Number of patents) | Ln (Private R&D investment) | Ln (New product sales) | Ln (Number of patents) | |
Method | Threshold regression | Threshold regression | Threshold regression | IV | IV | IV |
Ln (R&D subsidy) | 1.113** | 2.581** | 0.051** | 0.464** | 0.348** | 0.072** |
(0.696) | (1.349) | (0.027) | (0.242) | (0.169) | (0.039) | |
Ln (R&D subsidy) *T1 | 4.012*** | 3.804** | 0.094*** | 2.435*** | 1.508** | 0.104*** |
(2.001) | (2.189) | (0.042) | (0.877) | (0.981) | (0.007) | |
Ln (R&D subsidy) *T2 | −0.937** | −1.118* | 0.043** | −0.037** | −0.629* | 0.033** |
(0.467) | (0.865) | (0.027) | (0.017) | (0.591) | (0.018) | |
Ln (R&D subsidy) *T3 | 0.073*** | 0.52*** | 0.081*** | 0.068*** | 0.016*** | 0.092*** |
(0.021) | (0.115) | (0.012) | (0.008) | (0.007) | (0.025) | |
Ln (researchers) | 0.021 | 0.024 | 0.046 | 0.011 | 0.023 | 0.009 |
(1.088) | (1.329) | (0.988) | (0.895) | (1.126) | (1.116) | |
Ln (workers) | 0.125** | 0.023** | 0.053** | 0.025** | 0.025** | 0.301** |
(0.778) | (0.015) | (0.035) | (0.019) | (0.018) | (0.158) | |
Firm’s age | 0.115* | 0.241** | 0.351** | 0.132* | 0.119** | 0.129** |
(0.911) | (0.132) | (0.171) | (0.098) | (0.073) | (0.071) | |
Shareholding structure | 2.514*** | 1.446*** | 1.606*** | 2.509*** | 1.532*** | 1.781*** |
(0.098) | (0.651) | (0.554) | (1.007) | (0.632) | (0.119) | |
_cons | 0.924 | −0.424 | −0.442 | 0.558 | 2.118** | 1.610*** |
(1.310) | (0.626) | (2.095) | (1.415) | (0.933) | (0.389) | |
First stage F |
|
|
| 11.23 | 11.51 | 11.84 |
N | 6715 | 6715 | 6715 | 6715 | 6715 | 6715 |
adj.R2 | 0.111 | 0.131 | 0.139 | 0.122 | 0.139 | 0.198 |